Aplysin is an antineoplastic agent. Aplysin has been shown to suppress breast cancer cell activity via inhibition of the PI3K/AKT/FOXO3a pathway. Aplysin has also been shown to protect hepatocytes against oxidative damage. References: Shakeel E, Sharma N, Akhtar S, Khan MKA, Lohani M, Siddiqui MH. Decoding the antineoplastic efficacy of Aplysin targeting Bcl-2: A de novo perspective. Comput Biol Chem. 2018 Dec;77:390-401. doi: 10.1016/j.compbiolchem.2018.09.003. Epub 2018 Sep 6. PubMed PMID: 30469054.

纯度：≥98%

CAS：6790-63-2